Screening for chromosomal abnormalities using combined test in the first trimester of pregnancy.
OBJECTIVE
This study was designed to review the screening performance of combined test at the Ewha Womans University Mokdong hospital.


METHODS
All women admitted for routine antenatal care between January 1st 2008 and December 31st 2012 with a known pregnancy outcome were included in this study, totaling 1,156 women with singleton pregnancies presenting at 10 to 13 weeks of gestation. Women were offered screening using a combination of maternal serum pregnancy-associated plasma protein-A, free β-human chorionic gonadotropin and fetal nuchal translucency thickness. Those with an estimated risk of ≥1 in 250 of carrying a fetus with trisomy 21 or ≥1 in 300 risk of trisomy 18 were offered genetic counseling with the option of an invasive diagnostic test.


RESULTS
The median of gestational age was 11+3 weeks, the median of crown-rump length was 47.1 mm, and the median age of the women was 31 years. The detection rate was 80% for trisomy 21 (4 of 5) and 100% for trisomy 13 and 18 (all 2). The false-positive rate was 7.73% for trisomy 21 and 1.21% for trisomy 18.


CONCLUSIONS
This study was the first large population study performed with the aim of analyzing the performance of the combined test in Korea. This study demonstrated that the detection rates and other figures of the first trimester combined test are comparable to the results reported in other papers worldwide. Consequently, if strict conditions for good screening outcomes are achieved, the first trimester combined test might well be the earliest detectable screening, improving detection rates without increasing karyotyping or economic and other implications that inevitably ensue.
Department of Obstetrics and Gynecology, Ewha Womans University School of Medicine, Seoul, Korea.
Soo Yeon
SY
Park
Kwak Women's Hospital, Seongnam, Korea.
In Ae
IA
Jang
Department of Obstetrics and Gynecology, Ewha Womans University School of Medicine, Seoul, Korea.
Min Ah
MA
Lee
Department of Obstetrics and Gynecology, Ewha Womans University School of Medicine, Seoul, Korea.
Young Ju
YJ
Kim
Department of Obstetrics and Gynecology, Ewha Womans University School of Medicine, Seoul, Korea.
Sun Hee
SH
Chun
Department of Obstetrics and Gynecology, Ewha Womans University School of Medicine, Seoul, Korea.
Mi Hye
0000-0002-7205-0731
MH
Park
Combined test; Down screening; Fetal aneuploidy; First trimester screening; Prenatal diagnosis
Prenat Diagn. 1998 Mar;18(3):281-6
9556045
Ultrasound Obstet Gynecol. 2005 Mar;25(3):221-6
15736186
Obstet Gynecol. 2015 Oct;126(4):753-9
26348180
Obstet Gynecol. 1987 Aug;70(2):247-50
3299184
Prenat Diagn. 1997 Sep;17 (9):821-9
9316126
BMJ. 1992 Apr 4;304(6831):867-9
1392745
BJOG. 2000 Oct;107(10):1271-5
11028580
Prenat Diagn. 2005 Nov;25(11):984-90
16240322
Prenat Diagn. 2002 Mar;22(3):211-5
11920896
Prenat Diagn. 1999 Apr;19(4):360-3
10327142
Cochrane Database Syst Rev. 2003;(3):CD003252
12917956
Ultrasound Obstet Gynecol. 2016 Jan;47(1):45-52
26498918
Ultrasound Obstet Gynecol. 1997 Dec;10 (6):387-90
9476321
BJOG. 2003 Mar;110(3):281-6
12628268
Eur J Obstet Gynecol Reprod Biol. 2000 Sep;92 (1):97-101
10986441
J Med Screen. 2003;10 (2):56-104
14746340
Ultrasound Obstet Gynecol. 2008 Jun;31(6):618-24
18461550
Prenat Diagn. 1998 Sep;18(9):907-13
9793972
Obstet Gynecol. 2007 Jan;109 (1):217-27
17197615
BJOG. 2002 Jun;109 (6):667-76
12118646
BMJ. 1988 Oct 8;297(6653):883-7
2460174
Semin Perinatol. 2005 Aug;29(4):225-35
16104673
BMJ. 1993 Dec 4;307(6917):1455-8
7506599
Prenat Diagn. 1999 Nov;19(11):1035-42
10589055
Prenat Diagn. 2011 Dec;31(13):1241-5
22025131
BJOG. 2004 Jun;111(6):521-31
15198778
Taiwan J Obstet Gynecol. 2013 Dec;52(4):523-6
24411037
Health Technol Assess. 2003;7(11):1-77
12709291
N Engl J Med. 2005 Nov 10;353(19):2001-11
16282175
Br J Obstet Gynaecol. 1997 Jul;104(7):849-51
9236655
Ultrasound Obstet Gynecol. 1997 Jan;9(1):14-6
9060123